Cardiff University, School of Medicine, Cardiff, UK.
Department of Paediatric Neurosurgery, University Hospital of Wales, Cardiff, UK.
Clin Neurol Neurosurg. 2021 May;204:106608. doi: 10.1016/j.clineuro.2021.106608. Epub 2021 Mar 19.
We aim to evaluate whether intraoperative cerebrospinal fluid (CSF) sampling during ventriculo-peritoneal (VP) shunt insertion can predict future VP shunt infection or guide its management.
83 paediatric patients undergoing VP shunt insertion between February 2013 and July 2019 were retrospectively identified. Patient demographics, presence of pre-operative extra ventricular drain (EVD), pre-operative CSF results, and intra-operative CSF results were identified from patient case notes and electronic clinical databases. All included patients were followed up for a minimum of 6 months for identification of shunt infection.
90 VP shunt insertions were performed in 83 patients. Age at time of shunt insertion ranged from 5 days to 15.8 years (mean 44.2 months). Tumours were the most common aetiology for hydrocephalus (n = 24). 67 cases (74.4%) had intra-operative CSF samples, of which 2 revealed the presence of bacteria. Only 1 patient with intra-operative CSF sampling positive for growth developed shunt infection during follow up. Two cases developed a shunt infection despite normal intra-operative CSF results. Three cases did not have intra-operative CSF sampling but developed a shunt infection during follow up. Intra-operative CSF culture achieved 33.3% sensitivity and 98.4% specificity for predicting future shunt infection (p = 0.154). The Receiver Operator Characteristic (ROC) curve of intra-operative white cell count (WCC) and shunt infection at 6 months follow up yielded an Area Under the Curve (AUC) of 50.3%.
Our results show that intraoperative CSF sampling as a method to predict future risk of shunt infection and to help inform future antibiotic prescribing is unreliable. Given an AUC of 50.3%, it is no better than chance as a diagnostic tool. Further larger studies are needed to substantiate this.
评估脑室-腹腔(VP)分流植入术中脑脊液(CSF)取样是否可以预测未来的 VP 分流感染或指导其管理。
回顾性分析 2013 年 2 月至 2019 年 7 月期间接受 VP 分流植入术的 83 例儿科患者。从患者病历和电子临床数据库中确定患者的人口统计学特征、术前是否存在脑室外引流(EVD)、术前 CSF 结果和术中 CSF 结果。所有纳入的患者均至少随访 6 个月以确定分流感染。
83 例患者共进行了 90 次 VP 分流植入术。分流植入时的年龄为 5 天至 15.8 岁(平均 44.2 个月)。肿瘤是脑积水最常见的病因(n=24)。67 例(74.4%)患者有术中 CSF 样本,其中 2 例显示存在细菌。只有 1 例术中 CSF 样本呈阳性的患者在随访中发生分流感染。尽管术中 CSF 结果正常,但仍有 2 例发生分流感染。3 例未进行术中 CSF 取样,但在随访中发生分流感染。术中 CSF 培养对预测未来分流感染的敏感性为 33.3%,特异性为 98.4%(p=0.154)。术中白细胞计数(WCC)和 6 个月随访时分流感染的受试者工作特征(ROC)曲线的曲线下面积(AUC)为 50.3%。
我们的结果表明,术中 CSF 取样作为预测未来分流感染风险并帮助指导未来抗生素使用的方法不可靠。AUC 为 50.3%,作为诊断工具并不比随机更好。需要进一步的更大规模的研究来证实这一点。